---
title: Amid criticism, FDA narrows use of $56K Alzheimer’s drug, calls for probe [Updated]
date: "2021-07-09 16:42:45"
author: Ars Technica
authorlink: https://arstechnica.com/?p=1779094
tags:
- Ars-Technica
---
FDA now says drug should only go to those with mild disease—the only patients tested.